Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Obaid S. Shaikh"'
Autor:
Florian B. Mayr, Victor B. Talisa, Alexander D. Castro, Obaid S. Shaikh, Saad B. Omer, Adeel A. Butt
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-6 (2022)
Infection with the SARS-CoV-2 Omicron variant appears to cause milder disease in the general population than infection with Delta. Here the authors use data from the US Department of Veterans Affairs and demonstrate that this also applies to infectio
Externí odkaz:
https://doaj.org/article/4b31dfef8d4c43fcae9c09b42fa858fe
Publikováno v:
Case Reports in Gastroenterology, Vol 14, Iss 3, Pp 491-496 (2020)
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. The tumor carries poor prognosis with curative therapeutic options limited to surgical resection, tumor ablation, and liver transplantation. Rarely, there is spontaneous r
Externí odkaz:
https://doaj.org/article/01135098fad84cefb56587bb2acea949
Publikováno v:
EClinicalMedicine, Vol 40, Iss , Pp 101117- (2021)
Background: Breakthrough infections after SARS-CoV-2 infection have been reported. Clinical outcomes among persons with breakthrough infection are not known. Methods: We retrospectively identified all Veterans with a confirmed SARS-CoV-2 infection >1
Externí odkaz:
https://doaj.org/article/2081a515aeb04d8fa5b0041e49605b01
Publikováno v:
Clinical Infectious Diseases. 75:2161-2168
Background The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may be less effective against the Omicron variant than against earlier variants. With recent resurgence of SARS-CoV-2 cases, the role of booster doses of the
Publikováno v:
Clinical Infectious Diseases. 75:e617-e622
Background Persons on chronic hemodialysis have a significantly diminished humoral immune response to SARS-CoV-2 vaccines. Whether this translates to reduced vaccine effectiveness (VE) is unknown. Methods We used the US Department of Veterans Affairs
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections after vaccination have been reported. Outcomes among persons with breakthrough infection are poorly understood. Methods We identified all veterans with a
Publikováno v:
Annals of Internal Medicine
Data are urgently needed on the real-world effectiveness of the currently administered COVID-19 vaccines. This case–control study evaluated the short-term effectiveness of currently administered vaccines in preventing confirmed SARS-CoV-2 infection
Autor:
Margaret Mizah, Olufunso Agbalajobi, Wheytnie Alexandre, Shari Rogal, Marina Serper, Tami Coppler, Grace Zhang, Obaid S. Shaikh, Krupa Patel, Andrea Reid, Linda Calgaro, Susan Zickmund
Publikováno v:
GastroHep. 3:307-325
Relative Vaccine Effectiveness of a SARS-CoV-2 mRNA Vaccine Booster Dose Against the Omicron Variant
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
The current SARS-CoV-2 vaccines may be less effective against the Omicron variant. With recent resurgence of SARS-CoV-2 cases, the role of booster doses of the vaccine needs to be highlighted.Using a retrospective cohort study design emulating a targ
Publikováno v:
Case Reports in Gastroenterology, Vol 14, Iss 3, Pp 491-496 (2020)
Case Reports in Gastroenterology
Case Reports in Gastroenterology
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. The tumor carries poor prognosis with curative therapeutic options limited to surgical resection, tumor ablation, and liver transplantation. Rarely, there is spontaneous r